| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-3223(00)00923-9 |
| P698 | PubMed publication ID | 10978722 |
| P50 | author | David A. Lewis | Q28112847 |
| P2093 | author name string | M C Austin | |
| L A Glantz | |||
| P2860 | cites work | The cDNA and derived amino acid sequences for rat and human synaptophysin | Q24631501 |
| Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia | Q28293352 | ||
| The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease | Q29614948 | ||
| Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia | Q29618963 | ||
| Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia | Q32000373 | ||
| The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains | Q33878357 | ||
| Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. | Q34429775 | ||
| Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia | Q35947887 | ||
| Cytoarchitectonic Definition of Prefrontal Areas in the Normal Human Cortex: I. Remapping of Areas 9 and 46 using Quantitative Criteria | Q36684009 | ||
| A 38,000-dalton membrane protein (p38) present in synaptic vesicles | Q37691886 | ||
| Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect | Q39628495 | ||
| Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia | Q41482417 | ||
| Functional and anatomical aspects of prefrontal pathology in schizophrenia | Q41609625 | ||
| Synaptic loss in Alzheimer's disease and other dementias | Q41984306 | ||
| Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease | Q45295751 | ||
| Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. | Q45307345 | ||
| Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. | Q46022290 | ||
| Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections | Q46516860 | ||
| Decreased regional cortical gray matter volume in schizophrenia | Q48109683 | ||
| Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness | Q48172717 | ||
| Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging | Q48192520 | ||
| Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. | Q48256427 | ||
| The reduced neuropil hypothesis: a circuit based model of schizophrenia | Q48303124 | ||
| Synapsin I gene expression in the adult rat brain with comparative analysis of mRNA and protein in the hippocampus | Q48344995 | ||
| Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus. | Q48444623 | ||
| A profile of cortical gray matter volume deficits characteristic of schizophrenia | Q48460854 | ||
| Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles | Q48475060 | ||
| Widespread cerebral gray matter volume deficits in schizophrenia | Q48515822 | ||
| Synaptic targets of pyramidal neurons providing intrinsic horizontal connections in monkey prefrontal cortex | Q48546731 | ||
| Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia. | Q48577168 | ||
| Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity | Q48615018 | ||
| Post-transcriptional regulation of synaptic vesicle protein expression and the developmental control of synaptic vesicle formation. | Q48757809 | ||
| Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging | Q48854560 | ||
| Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics | Q48865852 | ||
| Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. | Q51014945 | ||
| Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. | Q52022559 | ||
| Topography of pyramidal neuron intrinsic connections in macaque monkey prefrontal cortex (areas 9 and 46) | Q72255105 | ||
| The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins | Q73142043 | ||
| Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia | Q73535859 | ||
| Quantification without pontification: choosing a method for counting objects in sectioned tissues | Q73712076 | ||
| P433 | issue | 5 | |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 389-397 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia | |
| P478 | volume | 48 |
| Q40594390 | A novel mechanism to explain protein abnormalities in schizophrenia based on the flavivirus resistance gene |
| Q33922855 | Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder |
| Q34541215 | An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes. |
| Q36800477 | Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder |
| Q28210352 | Cerebellar synaptic protein expression in schizophrenia |
| Q47954022 | Decrease in somatostatin-positive cell density in the amygdala of females with major depression |
| Q36073289 | GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders |
| Q40227588 | Gamma oscillation deficits and the onset and early progression of schizophrenia |
| Q34214883 | Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. |
| Q34404767 | Lack of change in markers of presynaptic terminal abundance alongside subtle reductions in markers of presynaptic terminal plasticity in prefrontal cortex of schizophrenia patients |
| Q34987919 | Lamina- and cell-specific alterations in cortical somatostatin receptor 2 mRNA expression in schizophrenia |
| Q47820010 | Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia |
| Q39452587 | Mechanisms regulating dendritic arbor patterning |
| Q27345087 | Molecular and Genetic Characterization of Depression: Overlap with other Psychiatric Disorders and Aging |
| Q49084552 | Perinatal oxygen restriction does not result in reduced rat frontal cortex synaptophysin protein levels at adulthood as opposed to postmortem findings in schizophrenia |
| Q38395725 | Prefrontal dysfunction and a monkey model of schizophrenia |
| Q47673850 | Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development |
| Q33932087 | Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia |
| Q34574517 | Reduced somatostatin in subgenual anterior cingulate cortex in major depression |
| Q45221811 | Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. |
| Q35093256 | Schizophrenia, neurodevelopment and corpus callosum |
| Q34399558 | Selective expression of KCNS3 potassium channel α-subunit in parvalbumin-containing GABA neurons in the human prefrontal cortex |
| Q47616784 | Sustained Molecular Pathology Across Episodes and Remission in Major Depressive Disorder |
| Q39838610 | Synapsin III acts downstream of semaphorin 3A/CDK5 signaling to regulate radial migration and orientation of pyramidal neurons in vivo |
| Q51743706 | Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures. |
| Q28189235 | Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins |
| Q93199338 | The Role of Dendritic Brain-Derived Neurotrophic Factor Transcripts on Altered Inhibitory Circuitry in Depression |
| Q30417098 | The Role of Genetic Sex in Affect Regulation and Expression of GABA-Related Genes Across Species |
| Q34555278 | Understanding the pathology of schizophrenia: recent advances from the study of the molecular architecture of postmortem CNS tissue |
| Q80415280 | [Synaptic vesicle proteins and psychiatric disorders] |
Search more.